The advancement of HMBD-001 in clinical development demonstrates translation of Hummingbird Bioscience’s AIMM platform from…
Continue ReadingHummingbird Bioscience is building an explainable toxicity graph, developed in collaboration with LynxKite, supported by…
Continue ReadingHummingbird Bioscience appoints Dr. James Garner as President. Dr. Garner will join the leadership team…
Continue ReadingHummingbird Bioscience has won the Asia Pacific Trailblazer Award at the 2026 AI Discovery Awards…
Continue ReadingHummingbird Bioscience, a biotherapeutics company discovering and developing transformative medicines for diseases with significant unmet…
Continue ReadingPercheron Therapeutics obtains exclusive worldwide rights to Hummingbird Bioscience’s HMBD-002 for further clinical development. Hummingbird…
Continue ReadingHummingbird Bioscience today announced the internal appointment of Dipti Thakkar, PhD, as Chief Operating Officer.
Continue ReadingCallio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs)…
Continue ReadingHummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today…
Continue ReadingHummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today…
Continue Reading
